Seom guidelines for the treatment of gastric cancer 2015
Martín-Richard, Marta (Institut d'Investigació Biomèdica Sant Pau)
Custodio, A. (Hospital Universitario Clínico San Carlos (Madrid))
García-Girón, C. (Hospital Universitario de Burgos)
Grávalos, C. (Hospital Universitario 12 de Octubre (Madrid))
Gomez, C. (Hospital Universitario 12 de Octubre (Madrid))
Jimenez-Fonseca, P. (Hospital Universitario Central de Asturias)
Manzano, Jose Luis (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Pericay, Carles (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT))
Rivera, F. (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria))
Carrato, A. (Hospital Universitario Ramón y Cajal (Madrid))
Universitat Autònoma de Barcelona. Departament de Medicina

Date:	2015
Abstract:	Gastric cancer is the fourth cause of death by cancer in Spain and a significant medical problem. Molecular biology results evidence that gastroesophageal junction tumors and gastric cancer should be considered as two independent entities with a different prognosis and treatment approach. Endoscopic resection in very early tumors is feasible. Neoadjuvant and adjuvant therapy in locally advanced resectable tumor increase overall survival and should be considered standard treatments. In stage IV tumors, platinum-fluoropyrimidine-based schedule, with trastuzumab in HER2-overexpressed tumors, is the first-line treatment. Different therapies in second line have demonstrated in randomized studies their clear benefit in survival improvement.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	Cardia ; Clinical guidelines ; Diagnosis ; Gastric adenocarcinoma ; Treatment
Published in:	Clinical & translational oncology, Vol. 17 Núm. 12 (january 2015) , p. 996-1004, ISSN 1699-3055

DOI: 10.1007/s12094-015-1456-y
PMID: 26691658

9 p, 396.1 KB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut d'Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP)
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Parc Taulí Research and Innovation Institute (I3PT
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut de Recerca Sant Pau
Articles > Research articles
Articles > Published articles